These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14095600)

  • 1. [CRITICAL STUDY, BASED ON 43 CASES, OF A COUMARIN ANTICOAGULANT: DICOUMOXYL (1-METHOXY-2,2-BIS-(4-HYDROXY-3-COU- MARINYL)-ETHANE)].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER F; TENETTE C; BARRUCAND D
    Sem Hop; 1963 Nov; 39():2392-9. PubMed ID: 14095600
    [No Abstract]   [Full Text] [Related]  

  • 2. [A RECENT SYNTHETIC ANTICOAGULANT: DICOUMOXYL (NETHOXY-L-BIS (HYDROXY-4-COUMARINYL-3)--2,2-ETHANE)].
    GILGENKRANTZ JM; CHERRIER F; BARRUCAND D; ROYER R; RENAUD J
    Ann Med Nancy; 1964 Jan; 3():115-25. PubMed ID: 14136374
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL EXPERIMENTATION WITH A NEW SYNTHETIC ANTICOAGULANT, A COUMARIN DERIVATIVE: 1-METHOXY-2, 2-BIS (4-HYDROXY-3-COUMARINYL)-ETHANE].
    HUTINEL P
    Lyon Med; 1964 Jun; 211():1569-604. PubMed ID: 14161671
    [No Abstract]   [Full Text] [Related]  

  • 4. [USE IN CARDIOLOGY OF A NEW ANTICOAGULANT: DICOUMOXYL (1-BIS-METHOXY (4-HYDROXY, 3-COUMARINYL) 2,2-ETHANE). APROPOS OF 29 CASES].
    MERIEL P; GALINIER F; BOUNHOURE JP; GAVALDA J
    Toulouse Med; 1964; 65():849-58. PubMed ID: 14204295
    [No Abstract]   [Full Text] [Related]  

  • 5. [STUDY OF THE THERAPEUTIC ACTION AND ANTICOAGULANT ACTIVITY OF L-METHOXY-2,2-BIS-(4-HYDROXY-3-COUMARINYL)-ETHANE (DICOUMOXYL)].
    GEOFFROY H; DAOUDI A; BENYAHIA M; BERRADA A
    Maroc Med; 1963 Aug; 42():614-6. PubMed ID: 14052100
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the anticoagulant action of a new derivative of coumarin: Dicoumoxyl (Methoxy-1-bis-hydroxy-4-coumarinyl 3)-2,2 ethane)].
    NEEL JL
    Gaz Med Fr; 1962 Nov; 69():3313-6. PubMed ID: 13937881
    [No Abstract]   [Full Text] [Related]  

  • 7. [Critical study of the use of a new anticoagulant, derived from coumarin: dicoumoxyl, 1-methoxy-2,2-bis (4-hydroxy-3-coumarinyl)-ethane].
    DELBOY C
    Gaz Med Fr; 1963 Feb; 70():735-42. PubMed ID: 14026667
    [No Abstract]   [Full Text] [Related]  

  • 8. [USE OF A NEW ANTICOAGULANT: THIOPORAN. EXPERIENCE WITH 50 CASES].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER JM; ROYER R; REBEIX G
    Ann Med Nancy; 1963 Jun; 2():1003-10. PubMed ID: 14067482
    [No Abstract]   [Full Text] [Related]  

  • 9. [THROMBOSIS SERVICE].
    DEUTSCH
    Wien Z Inn Med; 1964 Feb; 45():57-72. PubMed ID: 14155962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of a new anticoagulant: 1-methoxy-2,2-bis(4-hydroxy-3-coumarinyl)-ethane. (Apropos of 27 cases)].
    WAREMBOURG H; DELOMEZ M
    Lille Med; 1963; 8():560-2. PubMed ID: 13998884
    [No Abstract]   [Full Text] [Related]  

  • 11. [ANTICOAGULANT THERAPY].
    GOOSSENS N
    Ther Ggw; 1963 Nov; 102():1247-58. PubMed ID: 14109351
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDY OF DICOUMOXYL, 1-METHOY-2,2-BIS(4-HYDROXY-3-COUMARINYL)-ETHANE, IN SURGERY].
    VALLET G
    Ann Chir; 1963 Dec; 17():1645-8. PubMed ID: 14108982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of a new anticoagulant derived from coumarin: 1-methoxy-2, 2-bis(4-hydroxy-3-coumarinyl)-ethane].
    DELAHAYE JP; PLAUCHU G; FROMENT A
    Lyon Med; 1963 May; 209():1147-59. PubMed ID: 14026605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial with a new synthetic anticoagulant: methoxy-1-bis (hydroxy-4-coumarinyl-3)2,2-ethane].
    SIKORAV H; WIART JP
    Sem Hop; 1962 Mar; 38():1002-5. PubMed ID: 13912779
    [No Abstract]   [Full Text] [Related]  

  • 15. [PRACTICE OF ANTICOAGULANT THERAPY WITH SINTROM (APROPOS OF 100 OBSERVATIONS)].
    NICOLAS G; NICOLAS F; DUBIGEON M
    Clinique (Paris); 1964 Oct; 59():563-6. PubMed ID: 14228308
    [No Abstract]   [Full Text] [Related]  

  • 16. [ANTICOAGULANT THERAPY IN THE ACUTE PHASE OF MYOCARDIAL INFARCT. STUDY OF 246 CASES].
    JOHNSON R; GRATTON JD; PHANEUF G
    Union Med Can; 1964 Jul; 93():826-30. PubMed ID: 14175759
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE USE OF 2831 R.P. (COREPTIL) IN CARDIOVASCULAR DISEASE. REVIEW OF THE LITERATURE AND PERSONAL CONTRIBUTION].
    MARTELLI A; ROSSI S
    Arch Sci Med (Torino); 1963 Nov; 116():314-28. PubMed ID: 14098820
    [No Abstract]   [Full Text] [Related]  

  • 18. USE OF ANTICOAGULANT FOR CARDIOVASCULAR DISEASES WITH SPECIAL EMPHASIS OF THE INCIDENCE OF THROMBOEMBOLISM IN JAPAN.
    IKEDA M
    Yokufuen Chosa Kenkyu Kiyo; 1963 Dec; 38():1-16. PubMed ID: 14134975
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevention of impending cardiac infarction by anticoagulant treatment.
    SMITH KS; PAPP C
    Br Heart J; 1951 Oct; 13(4):467-74. PubMed ID: 14886466
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral anticoagulant therapy in myocardial infarction.
    SHAPIRO S
    Harofe Haivri Heb Med J; 1951; 2():195-202. PubMed ID: 14888075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.